Park Avenue Securities’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $336K | Buy |
+3,165
| New | +$336K | ﹤0.01% | 1235 |
|
|
2025
Q1 | – | Sell |
-2,521
| Closed | -$310K | – | 1366 |
|
|
2024
Q4 | $310K | Buy |
2,521
+412
| +20% | +$50.7K | ﹤0.01% | 1279 |
|
|
2024
Q3 | $235K | Sell |
2,109
-858
| -29% | -$95.6K | ﹤0.01% | 1282 |
|
|
2024
Q2 | $317K | Sell |
2,967
-36
| -1% | -$3.85K | ﹤0.01% | 1164 |
|
|
2024
Q1 | $362K | Sell |
3,003
-2,233
| -43% | -$269K | ﹤0.01% | 1095 |
|
|
2023
Q4 | $644K | Sell |
5,236
-292
| -5% | -$35.9K | 0.01% | 806 |
|
|
2023
Q3 | $716K | Buy |
+5,528
| New | +$716K | 0.01% | 698 |
|
|
2023
Q1 | – | Sell |
-3,100
| Closed | -$494K | – | 944 |
|
|
2022
Q4 | $494K | Buy |
3,100
+70
| +2% | +$11.2K | 0.01% | 781 |
|
|
2022
Q3 | $404K | Sell |
3,030
-993
| -25% | -$132K | 0.01% | 797 |
|
|
2022
Q2 | $628K | Buy |
4,023
+222
| +6% | +$34.7K | 0.01% | 624 |
|
|
2022
Q1 | $592K | Buy |
3,801
+1,119
| +42% | +$174K | 0.01% | 673 |
|
|
2021
Q4 | $342K | Buy |
2,682
+583
| +28% | +$74.3K | 0.01% | 870 |
|
|
2021
Q3 | $273K | Sell |
2,099
-678
| -24% | -$88.2K | 0.01% | 892 |
|
|
2021
Q2 | $493K | Buy |
2,777
+288
| +12% | +$51.1K | 0.01% | 639 |
|
|
2021
Q1 | $409K | Buy |
2,489
+446
| +22% | +$73.3K | 0.01% | 647 |
|
|
2020
Q4 | $337K | Sell |
2,043
-890
| -30% | -$147K | 0.01% | 636 |
|
|
2020
Q3 | $418K | Sell |
2,933
-317
| -10% | -$45.2K | 0.01% | 470 |
|
|
2020
Q2 | $359K | Buy |
3,250
+365
| +13% | +$40.3K | 0.01% | 462 |
|
|
2020
Q1 | $288K | Buy |
2,885
+1,164
| +68% | +$116K | 0.02% | 243 |
|
|
2019
Q4 | $257K | Buy |
+1,721
| New | +$257K | 0.01% | 506 |
|